Singapore markets closed
Straits Times Index
3,297.55 -26.98 (-0.81%) Nikkei
38,102.44 -712.12 (-1.83%) Hang Seng
17,936.12 -5.66 (-0.03%) FTSE 100
8,147.12 +0.26 (+0.00%) Bitcoin USD
65,587.90 -973.33 (-1.46%) CMC Crypto 200
1,368.83 -19.33 (-1.39%)
STOK Nov 2024 12.500 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 02:09PM EDT. Market open.
| Previous close | 3.4000 |
| Open | 3.4000 |
| Bid | 0.5500 |
| Ask | 2.7500 |
| Strike | 12.50 |
| Expiry date | 2024-11-15 |
| Day's range | 3.4000 - 3.4000 |
| Contract range | N/A |
| Volume | |
| Open interest | 4 |
Simply Wall St.We Think Stoke Therapeutics (NASDAQ:STOK) Can Afford To Drive Business Growth
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Business WireStoke Therapeutics to Present at Upcoming Investor Conferences in June
BEDFORD, Mass., June 03, 2024--Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating protein expression with RNA-based medicines, today announced that management will present at the following upcoming investor conferences:
GuruFocus.comInsider Sale: CEO Edward M. Kaye of Stoke Therapeutics Inc (STOK) Sells 42,350 Shares
On May 20, 2024, Edward M. Kaye, MD, Chief Executive Officer of Stoke Therapeutics Inc (NASDAQ:STOK), executed a significant stock transaction, selling 42,350 shares of the company.
© 2024 Yahoo. All rights reserved.